Tie-2 ligands, methods of making and uses thereof
CA 2202028 C · Owner: Davis, Samuel · Inventors: Bruno, Joanne; Davis, Samuel; Yancopoulos, George D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptor body which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth a method of promoting neovascularization a method of promoting the growth or , differentiation of a cell expressing the TIE-2 receptor a method of blocking , the growth or differentiation of a cell expressing the TIE-2 receptor …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 6, 1995 and granted December 20, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 6, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 6, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.